P-1107 - Anticholinergic side effects of antipsychotic medications

2012 ◽  
Vol 27 ◽  
pp. 1
Author(s):  
M. Ozbilen ◽  
C.E. Adams
Keyword(s):  
Side Effects ◽  
Antipsychotic Medications ◽  
Anticholinergic Side Effects

MIANSERIN AND MAPROTILINE BY THEIR ANTICHOLINERGIC SIDE EFFECTS

1992 ◽  
Vol 15 ◽  
pp. 419B ◽  
Author(s):  
T. KALELIOGLU ◽  
N. ERADAMLAR ◽  
E. KANTARCI ◽  
A. VERIMLI ◽  
L. ALPKAN ◽  
...  
Keyword(s):  
Side Effects ◽  
Anticholinergic Side Effects

scholarly journals Anticholinergic side effects

2015 ◽  
Vol 16 (2) ◽  
pp. 117-118 ◽  
Author(s):  
Koji Kamiya ◽  
Yasunari Kamiya ◽  
Haruo Niwa
Keyword(s):  
Side Effects ◽  
Anticholinergic Side Effects

scholarly journals Acute onset clozapine-induced hyperglycaemia: A case report

2019 ◽  
Vol 32 (2) ◽  
pp. e100045 ◽  
Author(s):  
Pradeep Kumar ◽  
Dheerendra Kumar Mishra ◽  
Nimisha Mishra ◽  
Sunil Ahuja ◽  
Gyanendra Raghuvanshi ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Case Report ◽  
Side Effects ◽  
Atypical Antipsychotic ◽  
Time Frame ◽  
Acute Onset ◽  
Antipsychotic Medications ◽  
Pathophysiological Mechanisms ◽  
Hypoglycaemic Agent

Clozapine is an atypical antipsychotic which is described to have higher efficacy among all available antipsychotic medications. Clozapine is reserved especially for resistant schizophrenia due to its side effects. Clozapine-induced metabolic syndrome and hyperglycaemia are common long-term side effects and are responsible for increased mortality in patients with schizophrenia. In this case, a patient with resistant schizophrenia was presented with acute-onset hyperglycaemia and delirium with the use of clozapine within a week. Withdrawal of clozapine in the patient led to the improvement in delirium and hyperglycaemia without the use of any hypoglycaemic agent. This case supports the notion that in certain cases clozapine can induce hyperglycemia through possible direct pathophysiological mechanisms within a shorter time frame.

Pulmonary embolism from persistent dilatation of the bladder secondary to anticholinergic side effects

2009 ◽  
Vol 31 (2) ◽  
pp. 187-189 ◽  
Author(s):  
Masanobu Ito ◽  
Kotaro Hatta ◽  
Koichi Miyakawa ◽  
Heii Arai
Keyword(s):  
Pulmonary Embolism ◽  
Side Effects ◽  
Anticholinergic Side Effects

Applied monitoring for tardive dyskinesia and other extrapyramidal side effects

2012 ◽  
Vol 1 (7) ◽  
pp. 159-163 ◽  
Author(s):  
John E. Kalachnik
Keyword(s):  
Side Effects ◽  
Early Detection ◽  
Tardive Dyskinesia ◽  
Antipsychotic Drugs ◽  
Standard Of Care ◽  
Magic Bullet ◽  
Assessment Instruments ◽  
Extrapyramidal Side Effects ◽  
Antipsychotic Medications ◽  
Prevention Model

While the rate of tardive dyskinesia (TD) and other extrapyramidal side effects (EPSE) is lower with second generation antipsychotic medications compared to first generation antipsychotic medications, these side effects remain of clinical concern. This paper reviews the basis for the continued concern and the importance of secondary prevention, or early detection, within the primary-secondary-tertiary prevention model. The importance of standardized assessment instruments, education, and training is reviewed. Given the widespread use of antipsychotic drugs, the fact that antipsychotic drugs are the standard of care for several psychiatric conditions (with little indication that the magic bullet is on the immediate horizon to replace current antipsychotic drugs) applied monitoring and the early detection of TD and EPSE takes on added importance.

Femoxetine and Eye FunctionA Study of Possible Anticholinergic Side Effects

1985 ◽  
Vol 18 (03) ◽  
pp. 231-234 ◽  
Author(s):  
K. Jeppesen ◽  
H. Fledelius
Keyword(s):  
Side Effects ◽  
Anticholinergic Side Effects

Deaths in the Central Mental Hospital

1989 ◽  
Vol 6 (2) ◽  
pp. 144-147 ◽  
Author(s):  
Marjorie Stokes ◽  
Art O'Connor
Keyword(s):  
Side Effects ◽  
Suicide Rate ◽  
Patient Population ◽  
Death Rate ◽  
Mental Hospital ◽  
Young Patients ◽  
Admission Rate ◽  
Total Period ◽  
Anticholinergic Side Effects

AbstractAll deaths occurring in the in-patient population of the Central Mental Hospital during the period 1963 to 1987 inclusive were examined. The death rate during the total period was 11.7 per 1,000 admissions. The suicide rate during the total period was 3.9 per 1,000 admissions – there had been no suicides during the most recent five year period. Although the admission rate has been rising since the mid-1970s, the death rate over the last fifteen years has remained stable.Many of the deaths prior to 1970 were in elderly long stay patients who died from natural causes. Five deaths in young patients are described separately – in two of these anticholinergic side effects of medication may have contibuted to the deaths. Seven suicides occcuring during the study period are described separately – four of these occurred in the months soon after admission.

Sign in / Sign up

Export Citation Format

Share Document